In 2026, out-of-pocket costs for covered Part D drugs are capped at $2,100. Once you reach this limit, you pay nothing for ...

CMS proposed several changes for the third round of Medicare drug price negotiations, including the potential inclusion of some drugs under Medicare Part B, in a draft guidance published May 12. The ...

Hospital groups push CMS to revise drug cost survey language that misleadingly implies mandatory hospital responses under OPPS rules.

A new study examines the potential impact of the Medicare Prescription Payment Plan (M3P)—an opt-in policy implemented in ...

Medicare's cap on out-of-pocket costs helps cancer patients and others taking expensive drugs. With less financial burden, patients can better afford their medications.

OVERLAND PARK, Kan., Dec. 2, 2025 /PRNewswire/ -- Quest Analytics, the leader in provider network design and management solutions, announced today that the Centers for Medicare & Medicaid Services ...

The Centers for Medicare and Medicaid Services has issued a proposed rule to drive down prescription drug costs in Medicaid by increasing price transparency. The rule would allow CMS to have more ...

WASHINGTON — Describing cuts to Medicaid reimbursement as “devastating” to retail pharmacies, Dennis Wiesner, senior director of privacy, regulatory, government and industry affairs, and pharmacy ...